日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase I/II clinical trial of a melanoma vaccine targeting shared non-mutated antigens and a shared mutated BRAF neoantigen with an agonistic CD40 antibody (CDX-1140) plus TLR3 agonist (poly-ICLC)

针对共同的非突变抗原和共同的突变BRAF新抗原的黑色素瘤疫苗的I/II期临床试验,采用激动性CD40抗体(CDX-1140)和TLR3激动剂(poly-ICLC)

Ninmer, Emily K; Petroni, Gina R; Gastman, Brian R; Gaughan, Elizabeth M; Isaacs, James M; Haden, Kathleen; Kaur, Varinder; Wages, Nolan A; Chianese-Bullock, Kimberly A; Smith, Kelly T; Wright, Paul; Bryant, Jennifer; Dunlap-Brown, Marya; Engel, Jack A; Bekiranov, Stefan; Mauldin, Ileana S; Truong, Thach-Giao; Bullock, Timothy N J; Slingluff, Craig L Jr

Glioblastoma survival in rural America: a 10-year experience from a quaternary care center

美国农村地区胶质母细胞瘤患者的生存情况:一家四级医疗中心的十年经验

Pack, Emily; Cifarelli, Christopher P; Bhatia, Sanjay; Lewis, Jeremy; Brandmeir, Nicholas; Gleckman, Aaron; Han, Peng Cheng; Wages, Nolan A; Dotson, Timothy Shaun; Denney, Morgan W; Wen, Sijin; Armistead, Matthew; Norouzi, Saeed; Aulakh, Sonikpreet

Improvements in Real-World Survival in the Setting of a Recent Paradigm Shift in Acute Myeloid Leukemia Treatment

急性髓系白血病治疗范式转变背景下,真实世界生存率的提高

Ho, Thuy N; Willard, Patrick; Murray, Graeme F; Liu, Li; Wages, Nolan; Lee, Hyun; Maher, Keri R

Applying the Partial Order Continual Reassessment Method to High-Dimensional Treatment Combinations

将部分顺序连续重评估方法应用于高维治疗组合

Chen, Weishi; Liu, Li; Wages, Nolan A; Mozgunov, Pavel

International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROR

早期剂量探索性肿瘤试验中患者报告结局研究目标的国际共识驱动建议:OPTIMISE-ROR

Alger, Emily; Aiyegbusi, Olalekan Lee; Dueck, Amylou C; Minchom, Anna; Pe, Madeline; Peipert, John D; Snyder, Claire; Symeonides, Stefan N; Wilson, Roger; Basch, Ethan; Qiao, Yu; Bates, Susan E; Bulbeck, Helen; Dean, Lizzie; Di Maio, Massimo; Hansen, Aaron R; Kholmanskikh, Olga; Kobayashi, Ken; Landers, Dónal; Le Tourneau, Christophe; Lee, J Jack; Ma, Brigette B Y; Marshall, Lynley V; Patel, Sheetal; Petrie, Joan; Pond, Gregory R; Prior, Kieran; Rantell, Khadija R; Reeve, John F; Solovyeva, Olga; Wages, Nolan A; Weber, Harald A; Calvert, Melanie J; Yap, Christina

A trial of radiolabeled antibody yttrium-90-FF-21101 for the treatment of advanced ovarian and other cancers

一项使用放射性标记抗体钇-90-FF-21101治疗晚期卵巢癌和其他癌症的试验

Mahalingam, Devalingam; Owonikoko, Taofeek K; Delpassand, Ebrahim; Mulcahy, Mary F; Kalyan, Aparna; Ulahannan, Susanna; Cheung, Kin; Izumi, Yasayuki; Johansen, Mary; Madden, Timothy; Shimoyama, Susumu; Subach, Ruth Ann; Suzuki, Takeaki; Wages, David S; Wheeler, Catherine; Richardson, Debra L

Design of a Phase I Drug Combination Study with Adaptive Allocation Based on Dose-Limiting Toxicity Attribution

基于剂量限制性毒性归因的自适应分配的 I 期药物组合研究设计

Wages, Nolan A; Horton, Bethany J; Liu, Li; Marchi, Enrica; Petroni, Gina R

Paclitaxel-induced neuroinflammation after systemic administration in male and female mice

紫杉醇全身给药后在雄性和雌性小鼠中诱导神经炎症

Caillaud, Martial; Rakholia, Yogesh; Soleo, Lauren; Mckiver, Bryan D; Toma, Wisam; Burton, Michael D; Wages, Nolan A; Das, Priyam; Imad Damaj, M

Neutralization of Marinobufagenin Demonstrates Efficacy In Vitro and In Vivo in Models of Pre-Eclampsia.

马林蟾毒金中和剂在体外和体内先兆子痫模型中均显示出疗效

Pantho Ahmed F, Zaman Mehruba, Afroze Syeda H, Wages John M, Yu Bo, Larrick James W, Kuehl Thomas J, Vora Niraj, Uddin Mohammad Nasir

Understanding the Role of Patient-Reported Outcomes for Decision-Making in Early-Phase Dose-Finding Clinical Trials

了解患者报告结局在早期剂量探索临床试验决策中的作用

Brown, Richard; Wages, Nolan A; Liu, Li; Sutton, Arnethea L; Poklepovic, Andrew S